Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
受益于“两票制” 卫信康2018年上半年营收同比增58.87%
Read online
受益于“两票制” 卫信康2018年上半年营收同比增58.87%
8月27日,西藏卫信康医药股份有限公司(卫信康)发布2018年半年报。报告显示,2018年1-6月公司实现营业收入29,992.94万元(USD43.88 million),较2017年同比增长58.87%,实现净利润5,655.63万元(USD8.27 million),较2017年同比下降12.68%。营业收入增长主要受益于"两票制"政策。目前卫信康主营产品分为自主生产和合作两大类,主要合作产品包括注射用12种复合维生素、注射用门冬氨酸钾镁、蔗糖铁注射液等。"两票制"政策下,产品由合作方按指...
Vitamins China E-News 201809(Chinese version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...